Stocks Overview

LAST PRICE
228.3300
TODAY'S CHANGE (%)
Trending Up3.3100 (1.4710%)

Bid / Lots
221.1000/ 5
Ask / Lots
234.0000/ 1
Open / Previous Close
223.3900 / 225.0200
Day Range
Low 221.6700
High 230.0999
52 Week Range
Low 189.4400
High 281.1200
Volume
949,485
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Tuesday's close: 225.02
Time	Volume	BIIB
09:32 ET	9103	223.345
09:34 ET	1122	223.965
09:36 ET	811	225.295
09:38 ET	11100	224.475
09:39 ET	1100	225.23
09:41 ET	941	225.55
09:45 ET	1113	226.7
09:48 ET	300	226.285
09:50 ET	300	226.25
09:52 ET	1448	226.14
09:54 ET	403	226.495
09:56 ET	400	226.45
09:57 ET	604	226.41
09:59 ET	966	226.33
10:01 ET	2324	225.93
10:03 ET	1962	226.89
10:06 ET	1633	226.54
10:08 ET	2839	227.37
10:10 ET	3315	227.63
10:12 ET	3065	227.585
10:14 ET	4017	228.51
10:15 ET	2562	228.16
10:17 ET	1500	227.45
10:19 ET	1736	227.23
10:21 ET	200	227.25
10:24 ET	4214	228.32
10:26 ET	3109	228.235
10:28 ET	1550	228.0775
10:30 ET	400	227.84
10:32 ET	955	227.62
10:33 ET	200	227.65
10:35 ET	5296	228.26
10:37 ET	4898	228.445
10:39 ET	800	228.045
10:42 ET	1440	227.24
10:44 ET	6556	227.25
10:46 ET	568	226.84
10:48 ET	1482	227.29
10:50 ET	300	227.34
10:51 ET	1496	227.9075
10:53 ET	2308	228.25
10:55 ET	400	228.75
10:57 ET	6123	228.765
11:00 ET	1100	228.375
11:02 ET	3021	227.94
11:04 ET	2004	227.43
11:06 ET	200	227.385
11:08 ET	988	227.875
11:09 ET	325	228.24
11:11 ET	5416	227.87
11:13 ET	101	227.8
11:15 ET	320	227.81
11:18 ET	1200	227.09
11:20 ET	950	227.25
11:22 ET	2512	227.415
11:24 ET	1305	227.53
11:26 ET	2035	226.97
11:27 ET	300	226.78
11:29 ET	5163	226.69
11:31 ET	1010	226.72
11:33 ET	800	225.95
11:36 ET	600	225.68
11:38 ET	1840	225.63
11:40 ET	2620	226.175
11:42 ET	1005	225.8733
11:44 ET	850	226.19
11:45 ET	4438	225.88
11:47 ET	1648	226.1
11:49 ET	400	226.115
11:51 ET	600	226.605
11:54 ET	200	226.43
11:56 ET	900	226.44
11:58 ET	1100	226.52
12:00 ET	1044	226.52
12:02 ET	376	226.3
12:03 ET	1035	225.97
12:05 ET	2494	226.12
12:07 ET	200	226.42
12:09 ET	401	226.69
12:12 ET	100	226.6
12:14 ET	1060	226.88
12:16 ET	750	227.135
12:18 ET	602	227.255
12:20 ET	1062	227.32
12:23 ET	1017	227.45
12:25 ET	2458	227.49
12:27 ET	1868	227.58
12:30 ET	600	227.43
12:32 ET	800	227.42
12:34 ET	900	227.3225
12:36 ET	1422	227.265
12:38 ET	1200	227.22
12:39 ET	3939	227.305
12:41 ET	1834	227.39
12:43 ET	400	227.26
12:45 ET	1546	227.7
12:48 ET	300	227.5201
12:50 ET	500	227.765
12:52 ET	700	227.785
12:54 ET	847	227.79
12:56 ET	640	227.805
12:57 ET	927	227.86
12:59 ET	300	227.8515
01:01 ET	2427	228.135
01:03 ET	9070	228.59
01:06 ET	10588	228.7
01:08 ET	1454	228.79
01:10 ET	300	228.79
01:12 ET	300	228.535
01:14 ET	1200	228.1101
01:17 ET	1829	228.545
01:19 ET	285	228.555
01:21 ET	321	228.555
01:24 ET	500	228.73
01:26 ET	600	228.91
01:28 ET	146	229.04
01:30 ET	400	228.99
01:32 ET	911	229.015
01:33 ET	807	228.88
01:35 ET	5586	228.875
01:37 ET	1296	228.865
01:39 ET	2327	229.29
01:42 ET	800	229.21
01:44 ET	243	229.185
01:46 ET	100	229.09
01:48 ET	1000	228.88
01:50 ET	430	228.57
01:51 ET	400	228.5
01:53 ET	1495	228.73
01:55 ET	425	228.4951
01:57 ET	2592	228.37
02:00 ET	823	228.33
02:02 ET	832	228.64
02:04 ET	457	228.78
02:06 ET	1210	228.19
02:08 ET	200	228.4
02:09 ET	200	228.82
02:11 ET	400	228.87
02:13 ET	100	229
02:15 ET	1420	229.15
02:18 ET	500	229.26
02:20 ET	1507	229.155
02:22 ET	600	229.31
02:24 ET	2750	229.78
02:26 ET	590	229.72
02:27 ET	100	229.495
02:29 ET	300	229.475
02:31 ET	719	229.41
02:33 ET	200	229.395
02:36 ET	519	229.23
02:38 ET	2843	229.53
02:40 ET	846	229.5171
02:42 ET	656	229.695
02:44 ET	400	229.58
02:45 ET	341	229.68
02:47 ET	1474	229.68
02:51 ET	3039	229.8725
02:54 ET	700	229.88
02:56 ET	2404	229.81
02:58 ET	1850	229.935
03:00 ET	1008	229.99
03:02 ET	200	229.73
03:03 ET	1800	229.53
03:05 ET	750	229.025
03:07 ET	300	228.72
03:09 ET	1359	229.08
03:12 ET	410	229
03:14 ET	600	229.04
03:16 ET	835	228.845
03:18 ET	2228	229.24
03:20 ET	787	229.335
03:21 ET	715	229.255
03:23 ET	1750	229.43
03:25 ET	801	229.535
03:27 ET	1800	229.1
03:30 ET	2046	229.09
03:32 ET	3384	229.26
03:34 ET	502	229.395
03:36 ET	2037	229.9
03:38 ET	1332	229.899
03:39 ET	518	229.7
03:41 ET	4473	228.611839
03:43 ET	1125	228.285
03:45 ET	6816	227.71
03:48 ET	6619	227.84
03:50 ET	6280	228.3
03:52 ET	6427	228.715
03:54 ET	7067	228.59
03:56 ET	10780	228.62
03:57 ET	9516	228.425
03:59 ET	14127	228.33

Data delayed at least 15 minutes.

Today

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesBIIB Biogen Inc	32.8B	28.5x	-18.14%
United StatesICLR ICON PLC	28.6B	40.5x	+4.68%
United StatesMRNA Moderna Inc	48.0B	-7.9x	---
United StatesGRFS Grifols SA	6.3B	26.3x	---
United StatesIQV IQVIA Holdings Inc	42.4B	31.4x	+46.62%
United StatesBNTX Biontech SE	20.6B	166.8x	---
As of 2024-07-17

Biogen Inc. is a global biopharmaceutical company focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. The Company’s marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS; and FUMADERM for the treatment of severe plaque psoriasis. It also has collaborations for the commercialization of LEQEMBI, ZURZUVAE, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS, LUNSUMIO, and COLUMVI. It commercializes a portfolio of biosimilars of advanced biologics including BENEPALI, IMRALDI, FLIXABI, and BYOOVIZ.

Contact Information

Headquarters: 225 Binney StreetCAMBRIDGE, MA, United States 02142
Phone: 781-464-2000
Fax: 302-636-5454

Executives

Independent Chairman of the Board: Caroline Dorsa
President, Chief Executive Officer, Director: Christopher Viehbacher
Chief Financial Officer, Executive Vice President: Michael McDonnell
Chief Human Resource Officer, Executive Vice President: Ginger Gregory
Executive Vice President, Chief Legal Officer: Susan Alexander

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$32.8B
Revenue (TTM)	$9.7B
Shares Outstanding	145.6M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	-0.04
EPS	$8.00
Book Value	$102.14
P/E Ratio	28.5x
Price/Sales (TTM)	3.4
Price/Cash Flow (TTM)	19.3x
Operating Margin	17.21%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Biogen Inc
NASDAQ:BIIBUnited States

Search Criteria

Charts

Recent News

Today

Biogen Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB, from 10 minutes ago by Dow Jones

The Schall Law Firm Invites Shareholders In Biogen Inc Who Incurred Losses To Initiate Dialogue Please Be Aware Of The Deadline In This Matter, from 39 minutes ago by Dow Jones

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen, from 2 hours ago by Dow Jones

Lead Plaintiff Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds Biogen Inc. (BIIB) Investors of Deadline in Securities Fraud Class Action Lawsuit, from 4 hours ago by Dow Jones

Shareholders that lost money on Biogen Inc. (BIIB) should contact Levi & Korsinsky about pending Class Action - BIIB, from 5 hours ago by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar